Clinical Trial Update: Topical Crisaborole in Patients with Alopecia Areata [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating topical crisaborole for alopecia areata has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Eucrisa (crisaborole)

Snippet

Sponsor: Tufts Medical Center | Conditions: Alopecia Areata | Phase 2 | Status: WITHDRAWN